Notice Title

Consent to the Distribution of a New Medicine

Publication Date
25 May 2023

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2023-go2130
Title
View PDF
File Type and Size
PDF (33 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Budesonide Te Arai
Active Ingredient: Budesonide 3mg
Dosage Form: Modified release capsule
New Zealand Sponsor: Te Arai BioFarma Limited
Manufacturer: Laboratorios Liconsa SA, Guadalajara, Spain


Dated this 19th day of May 2023.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).